The Streak That Wasn't Built to Last Forever
Five straight quarters of sequentially rising Adjusted EBITDA» - $(90.9)M → $66.2M → $194.9M → $211.0M (implied) → $240.9M → a record $300.2M - was always going to end at some point; no metric climbs in a straight line forever. It ended this quarter: Adjusted EBITDA came in at $238.7 million (margin 3.9%), down 20.5% from Q2's record, even as it still grew 22% year-over-year. That's the headline number, but it undersells what actually changed underneath it. This isn't a case of one segment's growth simply decelerating - both segments moved the wrong way at once for the first time since the two-segment structure began. Product Commerce's Segment Adjusted EBITDA margin dipped for the first time in a year, from 7.2% to 6.7%, while Developing Offerings' loss widened nearly 50% quarter-over-quarter, from $(107.4) million to $(160.8) million - the worst quarterly loss, in dollar terms, this segment has ever posted (see Segment Performance below).
Coupang's own revenue mix also flipped a pattern that had held for most of 2022 and 2023: reported net revenue grew 21% year-over-year to $6,183.6 million, faster than the 18% constant-currency» growth rate - meaning the Korean won strengthened against the dollar this quarter, a tailwind, rather than the headwind that trimmed reported growth in most prior quarters this site has covered. None of that changes the underlying story: net income was essentially flat year-over-year ($91.3 million vs $90.7 million) despite revenue growing 21%, because both segments gave back some of the operating leverage they'd been building.
The Prescription
Coupang should stop treating a five-quarter winning streak as proof the model is now self-sustaining and start explaining, segment by segment, what specifically drove this quarter's reversal. Product Commerce's margin dip and Developing Offerings' loss spike happened in the same quarter - that's either a coincidence worth naming (a shared cost driver, a seasonal timing issue, a one-off) or a sign the two segments are more linked than the "one funds the other" narrative suggests. Right now investors get "continued investments in our Eats and Taiwan offerings, and higher content costs for our Coupang Play offering" as the entire explanation for a loss that widened by roughly half again - the same three-bets-bundled-into-one-line problem flagged last quarter, now with a much bigger number attached to it.
What it should stop doing: adding new secured debt while simultaneously telling investors, in its own 10-Q, that "we expect our borrowings under debt financing arrangements to continue to increase" as a matter of course rather than a response to genuine capital need. Q4 2022's post, Q1 2023's post, and Q2 2023's post each flagged the same rising secured-borrowing pattern - this is the fourth straight quarter it's continued, with total short- and long-term debt now at roughly $1.142 billion, up from $842 million at year-end 2022. This quarter Coupang says the increase is a planned, ongoing feature of its fulfillment-center buildout, not a one-off - which makes the earlier "we don't need it, cash generation is strong enough" framing look less like restraint and more like a choice to keep pledging real estate as collateral even while free cash flow stays positive and growing.
Key Financial Metrics
Q3 2023 vs. Q3 2022, consolidated - reported in USD
Coupang reports natively in US dollars, so no FX conversion is needed here. Figures are drawn directly from this 10-Q's consolidated financial statements and MD&A tables, covering the fiscal quarter ended September 30, 2023.
| Metric | Q3 2023 | Q3 2022 | YoY |
|---|---|---|---|
| Total net revenues | $6,183.6M | $5,101.3M | ✅ +21% (+18% constant currency) |
| Gross profit | $1,565.8M | $1,233.9M | ✅ +27%, margin 25.3% vs 24.2% |
| Operating income | $87.5M | $77.4M | ✅ +13%, fifth straight profitable quarter |
| Adjusted EBITDA» | $238.7M | $194.9M | ⚠️ +22% YoY, but -20.5% QoQ - streak of 5 straight sequential gains broken |
| Net income | $91.3M | $90.7M | ⚠️ +0.7% - essentially flat despite 21% revenue growth |
| Net cash provided by operating activities | $721.6M | $58.2M | ⚠️ down from Q2's $819.8M, still strongly positive |
| Free cash flow» | $536.2M | $(222.4)M | ✅ fourth straight positive quarter, up from Q2's $449.9M |
| Cash & cash equivalents (period end) | $4,857.9M | n/a | ✅ +8.6% vs Jun 2023's $4,473.2M |
This is the fifth consecutive quarter of positive net income and Adjusted EBITDA, extending the run Q2 2023 built to a record - but it's also the first quarter in that run where Adjusted EBITDA fell sequentially rather than rising (see above).
| Balance sheet metric | Sep 2023 | Jun 2023 | Change |
|---|---|---|---|
| Total assets | $11,562.8M | $10,687.0M | ✅ +8.2% |
| Total liabilities | $8,634.4M | $7,911.5M | ⚠️ +9.1% |
| Total stockholders' equity | $2,928.4M | $2,775.5M | ✅ +5.5% |
Liabilities again grew faster than equity quarter-over-quarter, continuing the pattern Q2 2023 first noted: accounts payable and short/long-term debt both rose, together outpacing the $91.3 million of net income added to equity this quarter (accumulated deficit narrowed to $(5,415.2) million from $(5,506.5) million at Q2's end).
Segment Performance: Product Commerce vs. Developing Offerings
Coupang reports the same two segments as every quarter since Q1 2022: Product Commerce (core retail, marketplace, Rocket Fresh, and related advertising) and Developing Offerings (Coupang Eats, Coupang Play, Taiwan retail, and fintech).
| Metric | Product Commerce Q3 2023 | Product Commerce Q2 2023 | Developing Offerings Q3 2023 | Developing Offerings Q2 2023 |
|---|---|---|---|---|
| Net revenues | $5,966.0M | $5,681.6M | $217.5M | $156.3M |
| Revenue growth (sequential) | ✅ +5.0% | — | ✅ +39.2% | — |
| Revenue growth (YoY) | ✅ +20.6% | — | ✅ +41.1% | — |
| Segment Adjusted EBITDA | ⚠️ $399.5M (margin 6.7%) | $407.6M (margin 7.2%) | ⚠️ $(160.8)M (margin -73.9%) | $(107.4)M (margin -68.7%) |
Product Commerce's Segment Adjusted EBITDA dipped both in dollar terms (to $399.5 million from $407.6 million) and in margin (to 6.7% from 7.2%) - the first sequential pullback since Q1 2023's post first tracked this segment's four-quarter margin-expansion run. Revenue kept growing (+5.0% sequentially, +20.6% YoY), so this reads as margin giving ground to growth investment rather than the core business slowing down - but it's still the segment that had, until this quarter, done nothing but expand.
Developing Offerings' loss widened nearly 50% quarter-over-quarter, from $(107.4) million to $(160.8) million, even as revenue also jumped 39.2% sequentially - the segment is growing and burning faster at the same time, the opposite of the "grow into profitability" trajectory the segment's history (loss narrowing through most of 2022) had suggested. Management again attributes the wider loss to "continued investments in our Eats and Taiwan offerings, and higher content costs for our Coupang Play offering," the same undifferentiated three-bet bundle as last quarter (see The Prescription above). At a -73.9% margin on its own revenue, this is now the widest quarterly loss margin this segment has posted since the two-segment structure began.
Key Operational Metrics
| Metric | Q3 2023 (Sep 2023) | Q3 2022 (Sep 2022) | YoY |
|---|---|---|---|
| Active Customers | 20.421M | 17.992M | ✅ +13.5%, new record |
| Total net revenue per Active Customer | $303 | $284 | ✅ +6.7% |
| Quarter | Active Customers | Revenue per Active Customer |
|---|---|---|
| Q4 2022 | 18.115M | $294 |
| Q1 2023 | 19.010M | $305 |
| Q2 2023 | 19.713M | $296 |
| Q3 2023 | 20.421M | $303 |
Active Customers climbed to a sixth consecutive record - up nearly 710,000 sequentially, the largest single-quarter addition since Q4 2022 - and revenue per Active Customer recovered to $303 from Q2's dip to $296, reversing the FLC-driven decline this site flagged last quarter rather than extending it. Both customer growth and spend-per-customer improving together, after a quarter where the two metrics moved apart, is a cleaner read on underlying demand than either metric alone.
"Not available" again this filing: orders per customer, Rocket WOW membership subscriber count, and third-party seller/merchant count - none disclosed, consistent with every prior quarter.
Beyond the Usual
Two new derivative lawsuits piggybacked on the securities class action this quarter
In August 2023, two separate stockholders' derivative actions were filed in the same federal court as the Choi v. Coupang securities class action - first flagged in the FY2022 filing and amended in May 2023 to add fraud allegations. These new suits name certain current and former directors and officers as defendants, with Coupang itself named only as a nominal defendant, and assert claims of breach of fiduciary duty and unjust enrichment built on the same underlying factual allegations as the securities suit. A derivative action is a different legal animal from a class action - it's brought on behalf of the company against its own leadership, seeking governance reforms as well as damages - and its arrival is a sign plaintiffs' counsel see enough in the original claims to build a second legal track on top of them. Coupang states it believes all of these actions are without merit and that no reasonable estimate of loss can be made; the securities suit itself still shows no lead plaintiff confirmed in this filing.
Secured borrowing keeps rising, and management now frames it as structural rather than situational
Total short-term borrowings and current/long-term debt reached approximately $1.142 billion at quarter-end, up from $842 million at 2022 year-end - a pattern flagged in three straight prior posts. This quarter's 10-Q states plainly: "As we continue to build additional fulfillment centers, we expect our borrowings under debt financing arrangements to continue to increase." That's a materially different framing from earlier quarters, where each new facility read as a discrete, one-off financing decision - Coupang is now telling investors directly that rising secured debt is the ongoing cost of its fulfillment-center expansion plan, not a temporary bridge (see The Prescription above).
The Korea Fair Trade Commission's investigation into Coupang's private-label unit remains open, unchanged
Coupang's Q3 2023 filing repeats, largely verbatim, the same disclosure flagged in last quarter's antitrust-investigation finding: the KFTC's investigation into potential preferential treatment of Coupang Private Label Business, open since June 28, 2021, remains unresolved with no new procedural development disclosed this filing. A footnote that repeats itself without new detail across quarters is itself a data point - either the investigation is genuinely quiet, or Coupang has nothing new it's required to disclose; either way, a matter now running more than two years deserves tracking every quarter it resurfaces rather than being read as routine boilerplate.
A new fulfillment-center term loan added real estate as collateral again
In April 2023, Coupang entered a new three-year, $171 million term loan to finance a fulfillment center and land purchase, pledging up to $205 million of land and buildings as collateral at a fixed 6.76% rate - on top of a separate new one-year, $59 million general-purpose credit facility at a floating rate. Total loans outstanding under these debt-financing arrangements reached $910 million at quarter-end, up from $667 million at 2022 year-end, continuing the collateral-pledging pattern this site has tracked since 2022 (see Beyond the Usual above).
The 2021 revolving credit facility's LIBOR-to-SOFR transition took effect this quarter
Effective July 1, 2023, Coupang's 2021 revolving credit facility formally replaced LIBOR with the Secured Overnight Financing Rate (SOFR) as its benchmark, completing the amendment reached during Q2 2023. The facility remains entirely undrawn, so this is confirmation of a housekeeping change rather than new information about Coupang's own credit usage - the $1.0 billion facility stays available as an unused liquidity backstop.
An existing short-term syndicated loan was extended rather than refinanced with new terms
In September 2023, Coupang modified an existing one-year term syndicated loan agreement, extending its maturity to September 2024, with the remaining $67 million outstanding now bearing interest at 5.56%. Extending an existing facility's maturity rather than replacing it with a new one is a smaller housekeeping item than the new collateralized loans discussed above, but it's part of the same broader debt-financing footnote worth reading in full each quarter, not just skimming for new facilities.
Target Valuation Range
EV $26.2 billion, ~1.06x EV/Revenue. Bottom line: Coupang is trading at roughly 1.06x annualized quarterly revenue and 1.13x trailing-twelve-month revenue - within, but at the low end of, the 1.0-1.2x range this site has tracked since Q4 2022 - even though this is the first quarter in over a year where the underlying profitability trend (see above) moved backward rather than forward. The market isn't punishing the reversal much, but it also isn't rewarding five quarters of prior improvement with a re-rating.
Coupang closed Q3 2023 (September 29, 2023, the last trading day of the quarter) at $17.00, down 2.3% from $17.40 at the end of Q2 2023, and up 2.0% from $16.67 a year earlier. With 1,611,084,000 Class A shares and 174,803,000 Class B shares outstanding (1,785,887,000 total) at quarter-end, that implies a market capitalization of approximately $30.4 billion, down slightly from $31.0 billion three months earlier.
Using cash, cash equivalents, and restricted cash (current and long-term) of $5.261 billion against total debt (short-term borrowings, current portion of long-term debt, and long-term debt) of approximately $1.142 billion, net cash comes to roughly $4.118 billion, putting enterprise value at approximately $26.2 billion.
| Market cap → enterprise value | Q3 2023 |
|---|---|
| Share price (period-end) | $17.00 |
| Shares outstanding (Class A + B) | 1,785,887,000 |
| Market capitalization | $30.4 billion |
| Net cash (cash & equivalents less total debt) | $4.118 billion |
| Enterprise value | $26.2 billion |
| EV/Revenue sanity check | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Enterprise value | $27.4 billion | $26.2 billion | down |
| EV/Revenue | 1.17x | 1.06x | down |
- EV/Revenue» using Q3 2023 revenue annualized ($6.184 billion × 4 = $24.73 billion): ~1.06x, down from Q2 2023's ~1.17x.
- Using trailing-twelve-month revenue (FY2022's $20.583 billion, less 9M 2022's $15.256 billion, plus 9M 2023's $17.822 billion = $23.149 billion): ~1.13x, in line with the 1.0-1.2x range this site has tracked since Q4 2022.
DCF and reverse DCF (illustrative only): eleven quarters of public-company data now cover Q3 2021 through Q3 2023, including five consecutive quarters of GAAP profitability. Checking this quarter against Q2 2023's base case:
| Scenario | Assumption / outcome |
|---|---|
| Current (period-end close) | Actual EV/Revenue this quarter, for reference: 1.06x |
| Q2 2023 base case | The Q2 2023 base case called for Product Commerce's margin to keep expanding at a slower pace, Developing Offerings' loss to stabilize without necessarily narrowing, free cash flow to stay positive, and the multiple to hold in the 1.1-1.3x range. Free cash flow and the multiple both landed close (FCF positive at $536.2 million, multiple at ~1.06-1.13x, the low end of the predicted band). Both segment calls missed in the same direction: Product Commerce's margin didn't just slow its expansion, it contracted for the first time in a year, and Developing Offerings' loss didn't merely fail to narrow - it widened nearly 50% (see Segment Performance above). |
| Bear case for next quarter | Bear case for next quarter: Product Commerce's margin contraction continues into a second quarter (turning this quarter's dip into a trend rather than a blip), Developing Offerings' loss keeps widening without the segment-level detail this site has repeatedly asked for, the two new derivative suits (see Beyond the Usual above) draw expanded discovery or a consolidated complaint, and the market starts discounting the multiple below 1.0x on evidence that the five-quarter profitability run has genuinely stalled. |
| Base case for next quarter | Base case for next quarter: Product Commerce's margin stabilizes near this quarter's level rather than recovering to Q2's peak, Developing Offerings' loss holds roughly flat in dollar terms, free cash flow stays positive, and the multiple holds in the 1.0-1.2x range. |
| Bull case for next quarter | Bull case for next quarter: Product Commerce's margin resumes expanding as this quarter's investment spend proves temporary, Developing Offerings' loss narrows back toward Q2's level as the Eats/Taiwan/Play buildout matures, Active Customers and revenue per Active Customer keep climbing together as they did this quarter, and the multiple re-rates toward 1.3-1.5x on evidence that this quarter's reversal was a single-quarter blip rather than the start of a new trend. |
Coupang, Inc.'s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023, via the company's SEC filings.